Pangea brings a higher likelihood of success and reduced timeline in developing new medicines for patients. We optimize our success rates by focusing on compounds with prior evidence of safety and efficacy. Our ecosystem consists of four , our own AI database, as well as our impact arm PangeACT.
We have a higher likelihood of success and reduced timeline in developing new medicines for patients. We optimise our success rates and development time by focusing on nature-inspired compounds with prior evidence of safety and efficacy.
Our development programs
Pangea assembles uncorrelated programs across therapeutic areas, increasing the likelihood of successful commercialization. To date, four programs were launched: Kanna Health, the OTT program, KT program, and AH program.
A combination of technologies including AI, metabolomics, and chem-informatics enable the scalable discovery of natural products.
Our Impact Work
It is part of Pangea’s mission to preserve ethnobotanical knowledge and habitats. We are setting up the non-profit PangeACT, which aims to support a variety of projects in education, environment, and knowledge preservation.